Aurora Cannabis’ (ACB) Sell (D-) Rating Reiterated at Weiss Ratings

Weiss Ratings reaffirmed their sell (d-) rating on shares of Aurora Cannabis (NASDAQ:ACBFree Report) in a research report sent to investors on Friday morning,Weiss Ratings reports.

A number of other research analysts have also recently commented on the company. Zacks Research raised Aurora Cannabis from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Wall Street Zen downgraded shares of Aurora Cannabis from a “hold” rating to a “sell” rating in a research note on Friday, July 18th. Two research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy”.

Check Out Our Latest Stock Report on ACB

Aurora Cannabis Stock Up 2.7%

NASDAQ ACB opened at $5.25 on Friday. The company has a current ratio of 2.97, a quick ratio of 1.51 and a debt-to-equity ratio of 0.06. The company has a market cap of $295.16 million, a price-to-earnings ratio of -27.63 and a beta of 1.75. The company has a 50 day moving average of $5.26 and a 200-day moving average of $4.98. Aurora Cannabis has a 1-year low of $3.42 and a 1-year high of $6.91.

Aurora Cannabis (NASDAQ:ACBGet Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported ($0.19) EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.37). The company had revenue of $71.98 million for the quarter, compared to the consensus estimate of $96.83 million. Aurora Cannabis had a negative return on equity of 1.49% and a negative net margin of 5.66%. On average, equities research analysts expect that Aurora Cannabis will post 0.46 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of ACB. DKM Wealth Management Inc. acquired a new position in Aurora Cannabis during the second quarter worth about $42,000. JW Asset Management LLC bought a new stake in shares of Aurora Cannabis during the 1st quarter valued at approximately $58,000. Headlands Technologies LLC bought a new stake in shares of Aurora Cannabis during the 2nd quarter valued at approximately $66,000. Engineers Gate Manager LP acquired a new position in Aurora Cannabis during the 2nd quarter worth approximately $68,000. Finally, Silver Oak Securities Incorporated bought a new position in Aurora Cannabis in the 3rd quarter valued at approximately $112,000. Institutional investors own 47.63% of the company’s stock.

About Aurora Cannabis

(Get Free Report)

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.

Read More

Analyst Recommendations for Aurora Cannabis (NASDAQ:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.